Brief: Inovio And Akeso Announce Clinical Collaboration To Advance Novel Combination Therapy For Glioblastoma (Gbm)
04/03/2026 13:06
March 4 (Reuters) - Akeso Inc 9926.HK: INOVIO AND AKESO ANNOUNCE CLINICAL COLLABORATION TO ADVANCE NOVEL COMBINATION THERAPY FOR GLIOBLASTOMA (GBM) INOVIO - DOSING IN COMBINATION THERAPY TRIAL EXPECTED TO BEGIN IN H2 2026 Source text: ID:nPn86DCrda Further company coverage: 9926.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akeso
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Akeso drops most in nearly three months on discounted share sale
Brief: Akeso To Place 20 Million New Shares At HK$97.76 Per Share
Factbox: Major drugmakers turn to China for licensing deals